VIMTA LABS:
VIMTA LABS: Q4 SL NET PROFIT 183.2M RUPEES VS 124M (YOY); 215M (QOQ) VIMTA LABS: Q4 REVENUE 944.4M RUPEES VS 727M (YOY) VIMTA LABS: Q4 EBITDA 330.4M RUPEES VS 259M (YOY) || Q4 EBITDA MARGIN 34.98% VS 35.63% (YOY) VIMTA LABS: CO RECOMMENDED DIVIDEND OF 2 RUPEES PER SHARE VIMTA LABS: CO APPROVES FORAY INTO BIOLOGICS CONTRACT RESEARCH
#WatchOutFor#StockInNews#TechnicalViews#EquityResearch#Miscellaneous
102 likes·86 comments

















